Monday, June 30, 2025 6/30/2025

Selective targeting of ependymoma progenitor cells via BMI1 inhibition

Award Number: R21CA280148
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/20/2023
PERIOD OF PERFORMANCE END DATE: 12/31/2025

Group Awards By:

View Award Description

Selective targeting of ependymoma progenitor cells via BMI1 inhibition - PROJECT SUMMARY Ependymoma (EPN) is fatal in 50% of children and has not seen any therapeutic improvements in over 30 years. Standard therapy remains limited to surgery, radiation, and chemotherapy in limited situations. In the past decade our understanding of the molecular biology of EPN has been advanced by molecular analysis of patient samples but these advances have failed to improve outcomes. Genomic studies clearly define multiple subgroups including Posterior fossa A and B as well as supratentorial subgroups. Despite these advances the heterogeneity in EPN remains a problem. To address this problem, we performed single cell RNA sequencing analysis of EPN patient samples and identified an undifferentiated progenitor population that expresses high levels of pluripotent cell markers. In parallel we performed an unbiased epigenome-wide RNAi screen targeting 410 chromatin regulators to identify novel epigenetic regulators critical for EPN cell growth. We identified the Polycomb repressive complex 1 (PRC1) protein BMI1 as a top hit, that when depleted or chemically inhibited severely suppressed EPN cell growth. Interestingly BMI1 is most highly expressed in the undifferentiated population identified by our scRNA-seq and associated with worse outcomes. Importantly the functional significance of BMI1 has not previously been evaluated in EPN. We hypothesize that high expression of BMI1 promotes de-differentiation and self-renewal of the UEC subpopulation, thereby locking the cells in a highly tumorigenic stem-like state. To address our hypothesis, we will first investigate the inhibition of BMI1 function on PFA tumor cell self-renewal and differentiation of aggressive PFA subpopulations in vitro. We will then establish the therapeutic efficacy of targeting BMI1 with novel small molecule inhibitors in EPN in vivo. Completion of this work will establish a direct role for BMI1 in EPN stem cell differentiation and provide justification for use of BMI1 inhibitors in human pediatric clinical trials.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $181,741 )
2025	2025	THE REGENTS OF THE UNIV. OF COLORADO	13001 E 17TH PL STE F428	AURORA	CO	80045	ADAMS	USA	Cancer Treatment Research	000	2	2/13/2025	NON-COMPETING CONTINUATION	$163,567
2025	2025	THE REGENTS OF THE UNIV. OF COLORADO	13001 E 17TH PL STE F428	AURORA	CO	80045	ADAMS	USA	Cancer Treatment Research	001	2	5/22/2025	NON-COMPETING CONTINUATION	$18,174
														Subtotal = $181,741

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2023	THE REGENTS OF THE UNIVERSITY OF COLORADO	13001 E 17TH PL STE F428	AURORA	CO	80045	ADAMS	USA	Cancer Treatment Research	000	1	4/11/2024	NEW	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $218,089 )
2023	2023	REGENTS OF THE UNIVERSITY OF COLORADO, THE	13001 E 17TH PLACE F428	AURORA	CO	80045	ADAMS	USA	Cancer Treatment Research	000	1	4/20/2023	NEW	$218,089
														Subtotal = $218,089

Grand Total All Awards = $399,830

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Selective targeting of ependymoma progenitor cells via BMI1 inhibition

Award Number: R21CA280148

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/20/2023

PERIOD OF PERFORMANCE END DATE: 12/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer